Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment.
Fernandez-Boyanapalli RF, Falcone EL, Zerbe CS, Marciano BE, Frasch SC, Henson PM, Holland SM, Bratton DL. Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment. J Allergy Clin Immunol. 2015 Nov; 136(5):1399-1401.e3.